LOCALLY ADVANCED UNRESECTABLE NSCLC

Clinical trials for LOCALLY ADVANCED UNRESECTABLE NSCLC explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED UNRESECTABLE NSCLC trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can a targeted pill offer hope for stubborn lung cancer?

Disease control NO_LONGER_AVAILABLE

This study provides expanded access to sotorasib, an oral drug designed to target a specific genetic mutation (KRAS G12C) found in some non-small cell lung cancers. It is for adults with advanced or metastatic disease who have already tried standard treatments, including chemothe…

Matched conditions: LOCALLY ADVANCED UNRESECTABLE NSCLC

Sponsor: Amgen • Aim: Disease control

Last updated Aug 22, 2026 00:00 UTC

LOCALLY ADVANCED UNRESECTABLE NSCLC

Get alerted when new LOCALLY ADVANCED UNRESECTABLE NSCLC trials appear

Can a targeted pill offer hope for stubborn lung cancer?